⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors

Official Title: A Phase 3 Multicenter, Open Label, Randomized Study of XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors Not Amenable to Conventional Surgery

Study ID: NCT00090025

Study Description

Brief Summary: The main purpose of this study is to determine if XL119 is more effective than the combination of 5-fluorouracil (5FU) and leucovorin (LV) in prolonging the survival of subjects with advanced biliary tumors.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States

Long Beach VA Medical Center, Long Beach, California, United States

University of California, Irvine Medical Center, Orange, California, United States

Sharp Clinical Oncology Research, San Diego, California, United States

Pacific Hematology Oncology Associates, San Francisco, California, United States

Yale University School of Medicine, New Haven, Connecticut, United States

Tampa General Hospital, Tampa,, Florida, United States

Winship Cancer Institute, Emory University Hospital, Atlanta, Georgia, United States

Carle Clinic Association, Urbana, Illinois, United States

Medical Consultants, PC c/o Ball Cancer Center, Muncie, Indiana, United States

Oncology Associates, Cedar Rapids, Iowa, United States

Louisiana Oncology Associates, Lafayette, Louisiana, United States

Tufts - New England Medical Center, Boston, Massachusetts, United States

Josephine Ford Cancer Center at Henry Ford Health System, Detroit, Michigan, United States

West Michigan Cancer Center, Kalamazoo, Michigan, United States

Oncology Care Center PLLC, St. Joseph, Michigan, United States

Norris Cotton Cancer Center, Lebanon, New Hampshire, United States

Queens Hospital Center, Jamaica, New York, United States

SUNY Upstate Medical University, Syracuse, New York, United States

New York Medical College, Valhalla, New York, United States

Cancer Treatment and Research Center, Bismark, North Dakota, United States

Gabrail Cancer Center, Canton, Ohio, United States

Case Western Reserve University, Cleveland, Ohio, United States

Charleston Hematology Oncology, PA, Charleston, South Carolina, United States

The Sarah Cannon Cancer Center, Nashville, Tennessee, United States

Western Washington Oncology, Inc., Lacey, Washington, United States

University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States

Universitair Ziekenhuis Gent, Ghent, , Belgium

British Columbia Cancer Agency - Vancouver Centre, Vancouver, British Columbia, Canada

London Regional Cancer Centre, London, Ontario, Canada

Ottawa Regional Cancer Centre, Ottawa, Ontario, Canada

Centre Hospitalier Universite de Montreal, Montreal, Quebec, Canada

Jewish General Hospital, Montreal, Quebec, Canada

CHU - Hospital Jean Minjoz, Besancon cedex, , France

Hospital Ambroise Pare, Boulogne Billancourt, , France

Centre Oscar Lambret, Lille cedex, , France

Institut Gustave Roussy, Villejuif Cedex, , France

Charite Berlin der Humbold Universitat, Berlin, , Germany

Heinrich-Heine-Universitat-Dusseldorf, Dusseldorf, , Germany

Allgem. Krankenhaus St. Georg, Hamburg, , Germany

Medizinische Hochschule Hannover, Hannover, , Germany

Universitätsklinikum Johannes Gutenberg, Mainz, , Germany

Technischen Universitat Munchen, Munich, , Germany

Klinikum Grosshadern der Ludwig Maximilians Universitaet, Munich, , Germany

Universitätsklinikum Tübingen, Tübingen, , Germany

Universitatsklinikum Ulm, Ulm, , Germany

Orszagos Onkologiai Intezet, Budapest, , Hungary

Centro di Riferimento Oncologico di Aviano, Aviano, , Italy

Ospidale Civile di Livorno, Livorno, , Italy

Policlinico Universitario di Udine, Udine, , Italy

Centrum Onkologii - Instytut im. Marii, Warszawa, , Poland

Cancer Research Center named after N.N. Blokhin, RAMS, Moscow, , Russian Federation

Hospital Clinic i Provincial (Oncology Department), Barcelona, , Spain

Hospital Clínico San Carlos, Madrid, , Spain

Hospital 12 de Octubre, Madrid, , Spain

Hospital Regional Universitario Carlos Haya, Malaga, , Spain

Hospital Provincial de Pontevedra, Pontevedra, , Spain

Hospital Lozano Blesa, Zaragoza, , Spain

Leicester Royal Infirmary, Leicester, England, United Kingdom

Contact Details

Name: Afshin Dowlati, MD

Affiliation: Case Western Reserve University - Cleveland

Role: STUDY_CHAIR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: